Ameritas Advisory Services’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7K | Buy |
+679
| New | +$18.7K | ﹤0.01% | 1770 |
|
|
2023
Q2 | – | Sell |
-1,142
| Closed | -$167K | – | 1790 |
|
|
2023
Q1 | $167K | Sell |
1,142
-915
| -44% | -$134K | 0.01% | 823 |
|
|
2022
Q4 | $369K | Buy |
2,057
+332
| +19% | +$59.6K | 0.02% | 634 |
|
|
2022
Q3 | $204K | Sell |
1,725
-484
| -22% | -$57.2K | 0.01% | 708 |
|
|
2022
Q2 | $316K | Buy |
2,209
+327
| +17% | +$46.8K | 0.02% | 600 |
|
|
2022
Q1 | $324K | Sell |
1,882
-91
| -5% | -$15.7K | 0.01% | 641 |
|
|
2021
Q4 | $501K | Buy |
+1,973
| New | +$501K | 0.02% | 511 |
|